NBI-34041

high-affinity CRF1 (corticotropin-releasing factor receptor 1) receptor antagonist for attenuating elevated stress response

Also Known As:

2-(2,4-dichlorophenyl)-4-methyl-6-(1-propylbutyl)-7,8-dihydro-6H-1,3,6,8a-tetraazaacenaphthylene

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Foster, Alan C: 1 article (09/2007)
2.	Grigoriadis, Dimitri E: 1 article (09/2007)
3.	Holsboer, Florian: 1 article (09/2007)
4.	Ising, Marcus: 1 article (09/2007)
5.	Künzel, Heike E: 1 article (09/2007)
6.	Learned-Coughlin, Susan M: 1 article (09/2007)
7.	Uhr, Manfred: 1 article (09/2007)
8.	Zimmermann, Ulrich S: 1 article (09/2007)

1.	Anxiety Disorders (Anxiety Disorder) 09/01/2007 - "NBI-34041 demonstrates that inhibition of the CRF system is a promising target for drug development against depression and anxiety disorders."